Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Research Funding » PROOF Centre Uses Genome BC Funds for COPD Dx

PROOF Centre Uses Genome BC Funds for COPD Dx

Apr 17, 2012

This article has been updated with the names of the partners providing funding.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Canada's Prevention of Organ Failure (PROOF) Centre of Excellence in Vancouver will use C$1.5 million (US$1.5 million) in new funding to develop a biomarker-based test for determining a person's risk for having a lung attack.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

In a Different Lab

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Relief Bill Signed

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

Little Bit Improved

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

PLOS Studies on Anti-Viral Epigenetic Drugs, Liver Cancer Oncogene, Brazilian HIV Diversity

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.